Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment

By Mamori Satoshi   Suzuki Fumitaka   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 776-782

Springer Publishing Company

Access to resources Recommend Favorite

Effects of interferon treatment on the glucose metabolism of patients with chronic hepatitis C

By Nemesanszky E.   Pusztay M.   Csepregi A.  

European Journal of Internal Medicine, Vol. 11, Iss. 3, 2000-06 ,pp. : 151-155

Elsevier

Access to resources Recommend Favorite

Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA

By Ide T.   Sata M.   Suzuki H.   Uchimura Y.   Shirachi M.   Adachi N.   Tanikawa K.  

International Hepatology Communications, Vol. 7, Iss. 1, 1997-05 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya   Rahbin Nogol   Weiland Ola   Carlsson Tony   Oksanen Antti   Birk Markus   Davidsdottir Loa   Hagen Karin   Hultcrantz Rolf   Aleman Soo  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite

The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin

By Lee Sang Jin   Shin Jung Woo   Park Bo Ryung   Kim Chang Jae   Jung Seok Won   Kim Byunggyu   Jeong In Du   Bang Sung-Jo   Park Neung Hwa  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 5, 2012-05 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite